These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4033925

  • 21. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T, Alufuzoff I, Winblad B, Nordberg A.
    Brain Res; 1990 Jun 25; 521(1-2):329-32. PubMed ID: 1698512
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex.
    Mesulam MM, Geula C.
    Brain Res; 1992 Apr 10; 577(1):112-20. PubMed ID: 1521137
    [Abstract] [Full Text] [Related]

  • 26. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK, Esiri MM, Bowen DM, Smith CC.
    J Neurol Sci; 1982 Dec 10; 57(2-3):407-17. PubMed ID: 7161627
    [Abstract] [Full Text] [Related]

  • 27. Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.
    Schegg KM, Nielsen S, Zweig RM, Peacock JH.
    Prog Clin Biol Res; 1989 Dec 10; 317():437-52. PubMed ID: 2602428
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease.
    Schegg KM, Harrington LS, Neilsen S, Zweig RM, Peacock JH.
    Neurobiol Aging; 1992 Dec 10; 13(6):697-704. PubMed ID: 1491735
    [Abstract] [Full Text] [Related]

  • 30. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    Hirano S, Shinotoh H, Shimada H, Ota T, Sato K, Tanaka N, Zhang MR, Higuchi M, Fukushi K, Irie T, Kuwabara S, Suhara T.
    J Alzheimers Dis; 2018 Dec 10; 62(4):1539-1548. PubMed ID: 29562505
    [Abstract] [Full Text] [Related]

  • 31. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J, Sberna G, McLean CA, Small DH.
    J Neurochem; 1999 Apr 10; 72(4):1600-8. PubMed ID: 10098867
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease.
    Gaykema RP, Nyakas C, Horvath E, Hersh LB, Majtenyi C, Luiten PG.
    Neurobiol Aging; 1992 Apr 10; 13(3):441-8. PubMed ID: 1625774
    [Abstract] [Full Text] [Related]

  • 34. The cholinergic system in old age and Alzheimer's disease.
    Perry EK.
    Age Ageing; 1980 Feb 10; 9(1):1-8. PubMed ID: 7361631
    [Abstract] [Full Text] [Related]

  • 35. Cortical cholinergic markers in schizophrenia.
    Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL.
    Schizophr Res; 1994 May 10; 12(2):137-44. PubMed ID: 8043524
    [Abstract] [Full Text] [Related]

  • 36. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI, Geula C, Mesulam MM.
    Ann Neurol; 1993 Sep 10; 34(3):373-84. PubMed ID: 8363355
    [Abstract] [Full Text] [Related]

  • 37. Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
    Kish S, Karlinsky H, Becker L, Gilbert J, Rebbetoy M, Chang LJ, DiStefano L, Hornykiewicz O.
    J Neurochem; 1989 Apr 10; 52(4):1183-7. PubMed ID: 2522539
    [Abstract] [Full Text] [Related]

  • 38. Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats.
    Wang Y, Tian Q, Liu EJ, Zhao L, Song J, Liu XA, Ren QG, Jiang X, Zeng J, Yang YT, Wang JZ.
    J Cell Mol Med; 2017 Dec 10; 21(12):3515-3528. PubMed ID: 28656644
    [Abstract] [Full Text] [Related]

  • 39. Early growth response-1 regulates acetylcholinesterase and its relation with the course of Alzheimer's disease.
    Hu YT, Chen XL, Huang SH, Zhu QB, Yu SY, Shen Y, Sluiter A, Verhaagen J, Zhao J, Swaab D, Bao AM.
    Brain Pathol; 2019 Jul 10; 29(4):502-512. PubMed ID: 30511454
    [Abstract] [Full Text] [Related]

  • 40. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H, Hirano S, Sinotoh H, Ota T, Tanaka N, Sato K, Yamada M, Fukushi K, Irie T, Zhang MR, Higuchi M, Kuwabara S, Suhara T.
    Int J Geriatr Psychiatry; 2015 Nov 10; 30(11):1105-13. PubMed ID: 26280153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.